Canada · Health Canada Drug Product Database

DIGESTIVE DUAL PHASE ENZYMES

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 64654
DIN: 02241060
Form: Capsule
Company as listed by source: ABUNDANCE NATURALLY LTD
Source status: Cancelled Pre Market (2017-06-20)
Source last updated: 2025-03-22

Source-listed ingredients

LIPASE (RHIZOPUS NIVEUS) — 2250 UNIT
AMYLASE (ASPERGILLUS ORYZAE) — 3400 UNIT
PROTEASE (ASPERGILLUS ORYZAE) — 11000 UNIT
CELLULASE (ASPERGILLUS ORYZAE) — 5400 UNIT
LACTASE (ASPERGILLUS ORYZAE) — 3000 UNIT

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →